Article
Tumor necrosis factor-α promotes survival and phenotypic maturation of poly(I:C)-treated dendritic cells but impairs their Th1 and Th17 polarizing capability.
Cytotherapy - 1 May 2015
Thorne Ana, Tomić Sergej, Pavlović Bojan, Mihajlović Dušan, Džopalić Tanja, Čolić Miodrag
Abstract excerpt
BACKGROUND AIMS: Toll-like receptor (TLR)-3 synthetic agonist polyinosinic-polycytidylic acid (poly(I:C)) is a promising agent for dendritic cell (DC)-based anti-tumor vaccines because of its ability to induce a strong maturation of DCs, but such an effect is followed by stimulation of DC apoptosis. Tumor necrosis factor (TNF)-α may promote the survival of poly(I:C)-stimulated DCs, but it is not known in detail...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
